Navigation Links
Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT
Date:10/23/2007

NEW YORK, Oct. 23 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) will hold a conference call on Thursday, October 25, 2007 at 8:30 a.m. EDT to discuss the Third Quarter 2007 financial results. Michael S. Weiss, Chairman and Chief Executive Officer of the Company, will host the call. Keryx will announce its financial results for this period in a press release to be issued prior to the call.

In order to participate in the conference call, please call 1-800-909-7113 (U.S.), 1-785-830-1914 (outside the U.S.), call-in ID: KERYX. The audio recording of the conference call will be available for replay at http://www.keryx.com, for a period of 15 days after the call.

The press release announcing our financial results for this period will be posted on the Company's website, http://www.keryx.com, prior to the call.

About Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals, Inc. is focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer. Keryx's lead compound under development is Sulonex(TM) (sulodexide), previously referred to as KRX-101, a first-in-class, oral heparinoid compound for the treatment of diabetic nephropathy, a life-threatening kidney disease caused by diabetes. Sulonex is in a pivotal Phase III and Phase IV clinical program under a Special Protocol Assessment with the Food & Drug Administration. Additionally, Keryx is developing Zerenex(TM), an oral, inorganic, iron-based compound that has the capacity to bind phosphate and form n
'/>"/>

SOURCE Keryx Biopharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Digital Healthcare Conference 2007: Mounting obstacles for health IT
2. Biomedical engineering conference invites manufacturers
3. Conference to address small town development
4. Wisconsin to host SBIR Conference
5. Gaming conference explores interactive media in learning
6. Digital Healthcare Conference starts on a realistic note
7. Digital Healthcare Conference marks Wisconsins Healthcare IT Week
8. Third coast of biotechnology makes strong showing at VC conference
9. Why companies dont get invited to the DEMO conference
10. Giuliani will keynote RedPrairie Corporations user conference
11. Wicab to present BrainPort at Boston conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...5 DSM Pharmaceutical Products toda...nce with Galenix, Saint Jean D,Illac, France, wher...acturing partner for Galenix commercial products o...borate on business development opportunities co-ma...on the strength of Galenix in drug product develop...
(Date:11/5/2009)... Nov. 5 ThermoGenesis Co...tive products for processing and storing adult ste...ter of fiscal 2010. ,, For the quarter ended Se... $5.2 million, a 15 percent increase over revenues...The Company said the key contributors to the growt...
(Date:11/5/2009)...Newswire-FirstCall/ -- Transgenomic, Inc. (OTC Bul...ts for the quarter ended September 30, 2009. The C...bles that follow. ,, Third Quarter 2009 ,,....01 per share for the third quarter of 2009 as com... for the third quarter of 2008. ,, Net sales w...
(Date:11/5/2009)... 5 Cepheid (Nasdaq: CPH...eaking at the following investor conferences, and ... Credit Suisse Healthcare Conferenc...ber, 2009 at 10 a.m. Mountain Time, ...nd, Tuesday, 1 December, 2009 at 1...
Breaking Biology Technology:DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7Cepheid to Webcast Upcoming Financial Presentations 2
..., , , , Martin Simon, Petra Albrec..., Martin Simon, Petra Albrecht, and Helmut ... Germany, Department of Ecology , Andrs Jar... , With the help of the Eppendorf cMaste... expression of Paramecium primaurelia individual c...
..., , , , George Halley and Vincent ...5 Prime, Inc., Boulder, CO, USA , Vincent P...ion Lab, Westbury, , NY , , ...ve become very popular because of their convenienc...ic amplification. Typical Hot Start , enz...
..., , , , Abstract , , ...ws researchers to determine , the presence,...script in , the organism, tissue or cell of... synthesis of a cDNA copy of all the mRNA present... of the gene(s) of interest. Due to buffer incompa...
Other Biology Technology:Single-cell RT-PCR Analysis of Paramecium Primaurelia with the Eppendorf , cMaster RTplusPCR System 2Single-cell RT-PCR Analysis of Paramecium Primaurelia with the Eppendorf , cMaster RTplusPCR System 3Single-cell RT-PCR Analysis of Paramecium Primaurelia with the Eppendorf , cMaster RTplusPCR System 4Single-cell RT-PCR Analysis of Paramecium Primaurelia with the Eppendorf , cMaster RTplusPCR System 5Single-cell RT-PCR Analysis of Paramecium Primaurelia with the Eppendorf , cMaster RTplusPCR System 6Single-cell RT-PCR Analysis of Paramecium Primaurelia with the Eppendorf , cMaster RTplusPCR System 7HotMasterAn innovative Hot Start/Cold Stop technology for better , PCR* results 2HotMasterAn innovative Hot Start/Cold Stop technology for better , PCR* results 3HotMasterAn innovative Hot Start/Cold Stop technology for better , PCR* results 4HotMasterAn innovative Hot Start/Cold Stop technology for better , PCR* results 5HotMasterAn innovative Hot Start/Cold Stop technology for better , PCR* results 6HotMasterAn innovative Hot Start/Cold Stop technology for better , PCR* results 7cMaster RTplusPCR System for increased sensitivity and product length , in RT-PCR 2cMaster RTplusPCR System for increased sensitivity and product length , in RT-PCR 3cMaster RTplusPCR System for increased sensitivity and product length , in RT-PCR 4cMaster RTplusPCR System for increased sensitivity and product length , in RT-PCR 5cMaster RTplusPCR System for increased sensitivity and product length , in RT-PCR 6
(Date:11/8/2009)...loss of a gene through deletion of genetic materia...abnormalities in learning and behavior, said a con...dicine ( www.bcm.edu ) in a report that appears on...This research goes about 95 percent of the way to ...viduals to this gene," said Dr. Arthur L. Beaudet ...
(Date:11/6/2009)... in harmony with their arboreal hosts. But new res...their trees of choice, the ants can get destructiv...d in the November issue of the American Naturalis...ive trees, and it reopens a centuries-old debate o...ts and certain species of plants and trees have co...
(Date:11/5/2009)...le University have developed synthetic molecules c...HIV and HIV-infected cells, as well as to prostate... the Journal of the American Chemical Society , c...e diseases. , The molecules called "antibody-r...ibody-recruiting molecule targeting prostate cance...
Breaking Biology News(10 mins):Developmental delay could stem from nicotinic receptor deletion 2Ants are friendly to some trees, but not others 2New synthetic molecules trigger immune response to HIV and prostate cancer 21 in 6 health workers wont report in flu pandemic study by Ben Gurion U researchers 9397 11 in 6 health workers wont report in flu pandemic study by Ben Gurion U researchers 9397 21 in 6 health workers wont report in flu pandemic study by Ben Gurion U researchers 9397 3Wildfires set to increase 50 percent by 2050 9392 1Wildfires set to increase 50 percent by 2050 9392 2More Can Be Done to Slow Obesitys Toll on Health 3A Experts 52960 1More Can Be Done to Slow Obesitys Toll on Health 3A Experts 52960 2More Can Be Done to Slow Obesitys Toll on Health 3A Experts 52960 3More Can Be Done to Slow Obesitys Toll on Health 3A Experts 52960 4
...ing plastic waste, discarded lead-acid batteries a...ed attack under a new agreement signed by the Unit...al treaty body controlling hazardous wastes. The M...irobi, Kenya, by the UN Environment Programme (UNE...the Basel Convention on the Control of Transbounda...
...gene they suspect plays an important role in trigg...rops a century-and-a-half ago. , And the pathogen...nts of agricultural damage throughout the modern w.... , The scientists describe the gene, called Avr3...tion of the Proceedings of the National Academy of...
...oute of drug administration to improve patient com... skin patches are rapidly becoming an important he...arket share for the treatment of chronic condition...logy is set to make further inroads as transdermal...ay through the development and clinical trial proc...
Other Biology News:Researchers find gene that may be at root of potato blight 2Researchers find gene that may be at root of potato blight 3
Chaperone Sampler Kit from BD Biosciences Pharmingen
SH3 Proteins II Sampler Kit from BD Biosciences Pharmingen
Mouse Anti-SOCS3 Monoclonal Antibody, Unconjugated, Clone SOC-25 from BioLegend
Caveolin Sampler Kit from BD Biosciences Pharmingen
Biology Products: